The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Malygin V.L.

Kafedra psikhologicheskogo konsul'tirovaniia, psikhokorrektsii i psikhoterapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Konovalova O.E.

Interregional Department of Multiple Sclerosis at Moscow Clinical Hospital №24, Moscow, Russia;
Pirogov Russian National Research Medical University, Moscow, Russia

Pakhtusova E.E.

Kafedra psikhologicheskogo konsul'tirovaniia, psikhokorrektsii i psikhoterapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Dumbrova E.V.

Evdokimov Moscow State University of Medical Dentistry, Moscow, Russia

Tishina I.A.

Evdokimov Moscow State University of Medical Dentistry, Moscow, Russia

Malygin Ya.V.

Pirogov Russian National Research Medical University, Moscow

Anxiety and depressive psychopathological characteristics of patients with multiple sclerosis at different stages of disease

Authors:

Malygin V.L., Boĭko A.N., Konovalova O.E., Pakhtusova E.E., Dumbrova E.V., Tishina I.A., Malygin Ya.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2‑2): 58‑63

DOI: 10.17116/jnevro20191192258

Read: 7179 times

Download PDF (RU)
Contact the author
Table of contents

ANXIETY AND DEPRESSIVE PSYCHOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH MULTIPLE SCLEROSIS AT DIFFERENT STAGES OF DISEASE
ANXIETY AND DEPRESSIVE PSYCHOPATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH MULTIPLE SCLEROSIS AT DIFFERENT STAGES OF DISEASE

To cite this article:

Malygin VL, Boĭko AN, Konovalova OE, Pakhtusova EE, Dumbrova EV, Tishina IA, Malygin YaV. Anxiety and depressive psychopathological characteristics of patients with multiple sclerosis at different stages of disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2‑2):58‑63. (In Russ.)
https://doi.org/10.17116/jnevro20191192258

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
A personalized approach to the treatment of chro­nic tension headache and como­rbid mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):51-57
Comparing the effi­cacy of divo­zilimab and second-line treatments for rela­psing-remitting multiple scle­rosis in the Russian Fede­ration: a systematic review and network meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):58-68
Expe­rience with the use of amitriptyline for chro­nic pelvic pain asso­ciated with endo­metriosis. Russian Journal of Human Reproduction. 2025;(1):86-93
Prediction and prevention of burnout syndrome in health care professionals in high epidemic risk settings. Russian Journal of Preventive Medi­cine. 2025;(4):51-56
The state of mental health of migrant workers and citi­zens of the Russian Fede­ration: A comparative analysis as illu­strated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Arti­ficial inte­lligence capa­bilities in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21
Abstract:

Objective. To study the development of anxiety and depressive disorders in patients with exacerbated multiple sclerosis (MS). Material and methods. Forty-three patients with MS were included in the study (women 74.4%, mean age 33.1 years old). SCL-90-R and MASQ questionnaire were used to evaluate psychopathological symptoms. Results and conclusion. There is the high prevalence of symptoms of anxiety and depression in patients with MS. Other symptoms, including interpersonal sensitivity, hostility and decrease of stress response, are observed as well.

Keywords:

multiple sclerosis
depression
anxiety
SCL-90-R
MASQ

Authors:

Malygin V.L.

Kafedra psikhologicheskogo konsul'tirovaniia, psikhokorrektsii i psikhoterapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Konovalova O.E.

Interregional Department of Multiple Sclerosis at Moscow Clinical Hospital №24, Moscow, Russia;
Pirogov Russian National Research Medical University, Moscow, Russia

Pakhtusova E.E.

Kafedra psikhologicheskogo konsul'tirovaniia, psikhokorrektsii i psikhoterapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Dumbrova E.V.

Evdokimov Moscow State University of Medical Dentistry, Moscow, Russia

Tishina I.A.

Evdokimov Moscow State University of Medical Dentistry, Moscow, Russia

Malygin Ya.V.

Pirogov Russian National Research Medical University, Moscow

Close metadata

References:

  1. Gusev EI, Zavalishin IA, Boyko AN. Multiple sclerosis. Mo.: Real-time; 2011. (In Russ.)
  2. Taylor KL, Simpson S Jr, Jelinek GA, Neate SL, De Livera AM, Brown CR, O’Kearney E, Marck CH, Weiland TJ. Longitudinal Associations of Modifiable Lifestyle Factors With Positive Depression-Screen Over 2.5-Years in an International Cohort of People Living With Multiple Sclerosis. Front Psychiatry. 2018;9:526. https://doi.org/10.3389/fpsyt.2018.00526
  3. Jose Sa M. Psychological aspects of multiple sclerosis. Clin Neurol Neurosurg. 2008;110:868-877. https://doi.org/10.1016/j.clineuro.2007.10.001
  4. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW. Depression and multiple sclerosis. Neurology. 1996;46:628-632. https://doi.org/10.1212/WNL.46.3.628
  5. Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC. Mortality in patients with multiple sclerosis. Neurology. 2013;81:84-192. https://doi.org/10.1212/WNL.0b013e31829a3388
  6. Feinstein A, Pavisian B. Multiple sclerosis and suicide. Mult Scler. 2017;23:923-927. https://doi.org/10.1177/1352458517702553
  7. 7.Lewis VM, Williams K, Koko C, Woolmore J, Jones C, Powell T. Disability, depression and suicide ideation in people with multiple sclerosis. J Affect Disord. 2017;208:662-669. https://doi.org/10.1016/j.jad.2016.08.038
  8. Ovcharov VV, Buldakova NYu, Enikolopova EV, Boiko AN. Comparison of effects of antidepressants (opra, fluoxetin) in treatment of depression in multiple sclerosis patients. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2007;107(4 suppl 2):133-136. (In Russ.)
  9. Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J. Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev. 2011;16:C007255. https://doi.org/10.1002/14651858.CD007295
  10. Nathoo N, Mackie A. Treating depression in multiple sclerosis with antidepressants: A brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions. Mult Scler Relat Disord. 2017;18:177-180. https://doi.org/10.1016/j.msard.2017.10.004
  11. Mohr DC, Hart SL, Fonareva I, Tasch ES. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler. 2006;12(2):204-208.
  12. Hasselmann H, Bellmann-Strobl J, Ricken R, Oberwahrenbrock T, Rose M, Otte C, Adli M, Paul F, Brandt AU, Finke C, Gold SM. Characterizing the phenotype of multiple sclerosis — associated depression in comparison with idiopathic major depression. Multiple Sclerosis J. 2016;11:1476-1484.
  13. Pravatà E, Rocca MA, Valsasina P, Riccitell GC. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis. Mult Scler. 2017;23(14):1864-1874. https://doi.org/10.1177/1352458517692886
  14. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. https://doi.org/10.1002/ana.22366
  15. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017;17(2):167. https://doi.org/10.1016/S1474-4422(17)30470-2
  16. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-286. https://doi.org/10.1212/WNL.0000000000000560
  17. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444-1452.
  18. Malygin YaV. Klinicheskie varianty i terapiya rasstrojstv so stertymi sochetannymi trevozhno-depressivnymi proyavleniyami: Dis... kand. med. nauk. M. 2009. (In Russ.)
  19. Stroud NM, Minahan CL. The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis. Health Qual Life Outcomes. 2009;7:68. https://doi.org/10.1186/1477-7525-7-68
  20. Loprinzi PD, Mahoney S. Concurrent occurrence of multiple positive lifestyle behaviors and depression among adults in the United States. J Affect Disord. 2014;165:126-130. https://doi.org/10.1016/j.jad.2014.04.073
  21. Van Der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013;21:CD006102. https://doi.org/10.1002/14651858.CD006102
  22. Knippenberg S, Bol Y, Damoiseaux J, Hupperts R, Smolders J. Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue. Acta Neurol Scand. 2011;124:171-175. https://doi.org/10.1111/j.1600-0404.2010.01447
  23. Patti F, Pozzilli C, Montanari E, et al. Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult Scler. 2007;13(6):783-791.
  24. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, Bratina A, Zivadinov R. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol. 2001;248(5):416-421.
  25. Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z, Kinkel PR. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport. 2000;11(6):1153-1158.
  26. Rojas JI, Sanchez F, Patrucco L, Miguez J, Besada C, Cristiano E. Brain structural changes in patients in the early stages of multiple sclerosis with depression. Neurol Res. 2017;39(7):596-600. https://doi.org/10.1080/01616412.2017
  27. D’alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil. 2006;28:307-314. https://doi.org/10.1080/09638280500191753
  28. Boĭko OV. Quality of life studies in multiple sclerosis patients. Zhurnal Nevroljgii i Psikhiatrii im. S.S. Korsakova. 2014;114(10):105-113. (In Russ.)
  29. Fernandez-Jimenez E, Arnett PA. Impact of neurological impairment, depression, cognitive function and coping on quality of life of people with multiple sclerosis: A relative importance analysis. Mult Scler. 2015;21(11):1468-1472. https://doi.org/10.1177/1352458514562439
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.